Technology

Transmab™, Cell Membrane Penetration

InNexus' Transmab technology involves a modification of antibodies or antibody fragments that enables them to penetrate cell membranes and attack intracellular targets or to cross the epidermal barrier to allow use as a topical treatment. Transmab products can be applied directly at the site of an untoward inflammatory reaction (i.e. psoriasis) preventing the autoimmune event without the problematic consequences of systemic immunosuppression.

Article: TransMabs: Cell-Penetrating Antibodies, The Next Generation, Muller et al., 2005.